Home › Funds › DEARBORN PARTNERS LLC › CME
DEARBORN PARTNERS LLC position in CME
CME GROUP INC · Financials
DEARBORN PARTNERS LLC reported holding 83,993 shares of CME (CME GROUP INC) in its Q3 2026 13F filing — a position valued at US$22.0M, representing 1.34% of its reported portfolio and ranking #26 among its reported holdings. DEARBORN PARTNERS LLC has disclosed CME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How DEARBORN PARTNERS LLC's CME position evolved
DEARBORN PARTNERS LLC first disclosed a stake in CME in Q3 2023 at 2,862 shares (US$573K). The position peaked in Q1 2026 at 100,440 shares, worth US$29.7M. Across 13 filings, DEARBORN PARTNERS LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 83,993 shares valued at US$22.0M — a reduction of -8,081 shares quarter over quarter.. Notable position changes include a 63% trim in Q3 2024 (shares rose 5% over the following quarter), a 450% increase in Q2 2025 (shares fell 2% over the following quarter), a 712% increase in Q4 2025 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.86K | $573.03K | New |
| Q4 2023 | 3.28K | $691.40K | Add |
| Q1 2024 | 3.89K | $838.12K | Add |
| Q2 2024 | 3.89K | $764.38K | Hold |
| Q3 2024 | 1.44K | $316.63K | Reduce |
| Q4 2024 | 1.51K | $351.13K | Add |
| Q1 2025 | 2.18K | $578.86K | Add |
| Q2 2025 | 12.00K | $3.31M | Add |
| Q3 2025 | 11.65K | $3.15M | Reduce |
| Q4 2025 | 94.61K | $25.84M | Add |
| Q1 2026 | 100.44K | $29.67M | Add |
| Q2 2026 | 92.07K | $20.33M | Reduce |
| Q3 2026 | 83.99K | $22.00M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CME and 13F data
CME (CME GROUP INC) is a Financials company. 25 other funds we track also report a position in CME — the largest reported positions include Sanders Capital, LLC (US$1.33B), RAYMOND JAMES FINANCIAL INC (US$1.08B), Fidelity International (FIL) (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CME
- Sanders Capital, LLC 5.06M sh · $1.33B · Q3 2026
- RAYMOND JAMES FINANCIAL INC 4.14M sh · $1.08B · Q3 2026
- Fidelity International (FIL) 3.96M sh · $1.04B · Q3 2026
- Alphabet Inc. 3.48M sh · $912.74M · Q3 2026
- Mitsubishi UFJ Asset Management Co., Ltd. 2.85M sh · $746.64M · Q3 2026
- ROYAL BANK OF CANADA 3.28M sh · $725.35M · Q2 2026
- Capital Wealth Planning, LLC 3.22M sh · $711.67M · Q2 2026
More on DEARBORN PARTNERS LLC
FAQ
How long has DEARBORN PARTNERS LLC held CME?
DEARBORN PARTNERS LLC has disclosed CME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is DEARBORN PARTNERS LLC's current position in CME?
As of Q3 2026, DEARBORN PARTNERS LLC holds 83.99K shares of CME (CME GROUP INC), valued at $22.00M, representing 1.34% of its reported portfolio and ranking #26.
Has DEARBORN PARTNERS LLC been buying or selling CME?
In the latest 13F filing (Q3 2026), DEARBORN PARTNERS LLC reduced its position in CME. The position peaked in Q1 2026 at 100.44K shares.
Which other funds hold CME?
Other major institutional holders of CME include Sanders Capital, LLC, RAYMOND JAMES FINANCIAL INC, Fidelity International (FIL), among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.